J. Mark Sloan, MD

Associate Professor, Medicine

J. Sloan
617.638.7520
820 Harrison Ave

Biography

Factotum hematologist at Boston Medical Center and Associate Professor at Boston University School of Medicine. Program director for the hematology/oncology fellowship at Boston University.I see patients with a variety of benign and malignant blood disorders. I have particular research interests in AL Amyloidosis, HTLV-1 associated leukemia/lymphoma (ATLL), and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN). Exceptional Care Without Exception.

Other Positions

  • Member, BU-BMC Cancer Center, Boston University
  • Member, Amyloidosis Center, Boston University
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University

Education

  • Yale University School of Medicine, MD
  • Harverford College, BS

Classes Taught

Publications

  • Published on 7/3/2020

    Gupta VK, Strykowski R, Scarpato B, Lawrence R, Khan SL, Patel J, Nouraie SM, Cohen RT, Sloan JM, Klings ES. The Effect of Anticoagulant Choice on Venous Thromboembolism Recurrence and Bleeding in Sickle Cell Disease. Am J Hematol. 2020 Jul 03. PMID: 32619024.

    Read at: PubMed
  • Published on 6/19/2020

    Dumas B, Yameen H, Sarosiek S, Sloan JM, Sanchorawala V. Presence of t(11;14) in AL amyloidosis as a marker of response when treated with a bortezomib-based regimen. Amyloid. 2020 Jun 19; 1-6. PMID: 32551974.

    Read at: PubMed
  • Published on 4/30/2020

    Sanchorawala V, Sarosiek S, Schulman A, Mistark M, Migre ME, Cruz R, Sloan JM, Brauneis D, Shelton AC. Safety, tolerability, and response rates of daratumumab in relapsed AL amyloidosis: results of a phase 2 study. Blood. 2020 Apr 30; 135(18):1541-1547. PMID: 31978210.

    Read at: PubMed
  • Published on 3/24/2020

    Kaufman AR, Quillen K, Distefano AG, Sloan JM. Nonsecretory Recurrence of Multiple Myeloma Presenting as Sixth Nerve Palsy Secondary to Clival Plasmacytoma. J Neuroophthalmol. 2020 Mar 24. PMID: 32235225.

    Read at: PubMed
  • Published on 3/9/2020

    Angel-Korman A, Stern L, Angel Y, Sarosiek S, Menn-Josephy H, Francis J, Ghai S, Sloan JM, Sanchorawala V, Havasi A. The Role of Kidney Transplantation in Monoclonal Ig Deposition Disease. Kidney Int Rep. 2020 Apr; 5(4):485-493. PMID: 32274452.

    Read at: PubMed
  • Published on 11/26/2019

    Staron A, Kataria Y, Murray DL, Sloan JM, Sanchorawala V. Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: A zebra without stripes. Am J Hematol. 2020 02; 95(2):E45-E48. PMID: 31736101.

    Read at: PubMed
  • Published on 10/4/2019

    Gupta VK, White PS, Brauneis D, Shelton AC, Quillen K, Sanchorawala V, Sarosiek S, Sloan JM. Safety of autologous stem cell transplantation in patients with known Human T-cell Lymphotropic Viruses Type 1 and 2 infection: A case series of four patients. Am J Hematol. 2019 12; 94(12):E317-E319. PMID: 31489689.

    Read at: PubMed
  • Published on 8/2/2019

    Pudusseri A, Sanchorawala V, Sloan JM, Bever KM, Doros G, Kataria S, Sarosiek S. Prevalence and prognostic value of D-dimer elevation in patients with AL amyloidosis. Am J Hematol. 2019 10; 94(10):1098-1103. PMID: 31292986.

    Read at: PubMed
  • Published on 7/10/2019

    Sloan JM. Lessons in Long Term Survival from AL Amyloidosis. Br J Haematol. 2019 12; 187(5):557-558. PMID: 31290565.

    Read at: PubMed
  • Published on 4/25/2019

    Pemmaraju N, Lane AA, Sweet KL, Stein AS, Vasu S, Blum W, Rizzieri DA, Wang ES, Duvic M, Sloan JM, Spence S, Shemesh S, Brooks CL, Balser J, Bergstein I, Lancet JE, Kantarjian HM, Konopleva M. Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm. N Engl J Med. 2019 04 25; 380(17):1628-1637. PMID: 31018069.

    Read at: PubMed

View 51 more publications: View full profile at BUMC

View all profiles